Lipocine Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lipocine Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • Lipocine Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 5.35M shares, a 2.16% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.35M +113K +2.16% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 5.32M -83.2M -94% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 5.32M +81K +1.55% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 5.32M -83.2M -94% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 5.23M -83.3M -94.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 88.5M +11.9K +0.01% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 5.23M -83.1M -94.1% Dec 31, 2022 10-K 2024-03-07
Q3 2022 88.5M +220K +0.25% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 88.5M +208K +0.24% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 88.5M +208K +0.24% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 88.3M +18.3M +26.1% Dec 31, 2021 10-K 2023-03-10
Q3 2021 88.3M +22.6M +34.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 88.3M +26.9M +43.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 88.3M +40.4M +84.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 70M +32.4M +86% Dec 31, 2020 10-K 2022-03-09
Q3 2020 65.7M +40.7M +162% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 61.4M +36.7M +148% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 47.9M +23.3M +94.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 37.6M +15.9M +73.2% Dec 31, 2019 10-K 2021-03-11
Q3 2019 25M +3.69M +17.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 24.7M +3.46M +16.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 24.6M +3.31M +15.6% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 21.7M +467K +2.2% Dec 31, 2018 10-K 2020-03-13
Q3 2018 21.3M +154K +0.73% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 21.3M +683K +3.32% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 21.3M +2M +10.4% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 21.3M +2.81M +15.2% Dec 31, 2017 10-K 2019-03-06
Q3 2017 21.2M +2.93M +16% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 20.6M +2.33M +12.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 19.3M +1.01M +5.54% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 18.5M +212K +1.16% Dec 31, 2016 10-K 2018-03-12
Q3 2016 18.3M +9.45K +0.05% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 18.3M +52.2K +0.29% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 18.3M +5.41M +42.1% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 18.2M +5.45M +42.6% Dec 31, 2015 10-K 2017-03-06
Q3 2015 18.2M +5.47M +42.8% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 18.2M +5.43M +42.5% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 12.8M +84.2K +0.66% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 12.8M +126K +1% Dec 31, 2014 10-K 2016-03-10
Q3 2014 12.8M +1.83M +16.7% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 12.8M +9.27M +265% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 12.8M +9.26M +265% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 12.7M +8.21M +184% Dec 31, 2013 10-K 2015-03-11
Q3 2013 11M +7.45M +213% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 3.5M Jun 30, 2013 10-Q 2013-07-09
Q1 2013 3.5M Mar 31, 2013 10-Q 2013-04-24
Q4 2012 4.46M +1.46M +48.5% Dec 31, 2012 10-K 2014-03-31
Q3 2012 3.5M Sep 30, 2012 10-Q 2012-10-26
Q4 2011 3M Dec 31, 2011 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.